332 related articles for article (PubMed ID: 27925499)
61. Adolescents' commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates.
Moses T
Child Psychiatry Hum Dev; 2011 Feb; 42(1):93-117. PubMed ID: 20953829
[TBL] [Abstract][Full Text] [Related]
62. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
63. Adolescent experience of psychotropic treatment.
Floersch J; Townsend L; Longhofer J; Munson M; Winbush V; Kranke D; Faber R; Thomas J; Jenkins JH; Findling RL
Transcult Psychiatry; 2009 Mar; 46(1):157-79. PubMed ID: 19293284
[TBL] [Abstract][Full Text] [Related]
64. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
65. Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns.
Koelch M; Prestel A; Singer H; Keller F; Fegert JM; Schlack R; Hoelling H; Knopf H
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):765-70. PubMed ID: 20035595
[TBL] [Abstract][Full Text] [Related]
66. Concomitant psychotropic medication for youths.
Safer DJ; Zito JM; DosReis S
Am J Psychiatry; 2003 Mar; 160(3):438-49. PubMed ID: 12611822
[TBL] [Abstract][Full Text] [Related]
67. Trends in the use of psychotropic medications among adolescents, 1994 to 2001.
Thomas CP; Conrad P; Casler R; Goodman E
Psychiatr Serv; 2006 Jan; 57(1):63-9. PubMed ID: 16399964
[TBL] [Abstract][Full Text] [Related]
68. Role of adverse effects in medication nonadherence in bipolar disorder.
Mago R; Borra D; Mahajan R
Harv Rev Psychiatry; 2014; 22(6):363-6. PubMed ID: 25377611
[TBL] [Abstract][Full Text] [Related]
69. Predictors of medication compliance after hospital discharge in adolescent psychiatric patients.
Lloyd A; Horan W; Borgaro SR; Stokes JM; Pogge DL; Harvey PD
J Child Adolesc Psychopharmacol; 1998; 8(2):133-41. PubMed ID: 9730079
[TBL] [Abstract][Full Text] [Related]
70. "Drugs Don't Work in Patients Who Don't Take Them".
Mechler K; Häge A
Z Kinder Jugendpsychiatr Psychother; 2019 Nov; 47(6):528-534. PubMed ID: 30681404
[No Abstract] [Full Text] [Related]
71. Patterns of adherence to treatment in adolescents with bipolar disorder.
Coletti DJ; Leigh E; Gallelli KA; Kafantaris V
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):913-7. PubMed ID: 16379511
[TBL] [Abstract][Full Text] [Related]
72. A theoretical approach to medication adherence for children and youth with psychiatric disorders.
Charach A; Volpe T; Boydell KM; Gearing RE
Harv Rev Psychiatry; 2008; 16(2):126-35. PubMed ID: 18415884
[TBL] [Abstract][Full Text] [Related]
73. Use of a computerized medication shared decision making tool in community mental health settings: impact on psychotropic medication adherence.
Stein BD; Kogan JN; Mihalyo MJ; Schuster J; Deegan PE; Sorbero MJ; Drake RE
Community Ment Health J; 2013 Apr; 49(2):185-92. PubMed ID: 22837104
[TBL] [Abstract][Full Text] [Related]
74. Delusional infestation and patient adherence to treatment: an observational study.
Ahmed A; Bewley A
Br J Dermatol; 2013 Sep; 169(3):607-10. PubMed ID: 23600661
[TBL] [Abstract][Full Text] [Related]
75. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
[TBL] [Abstract][Full Text] [Related]
76. Recent international trends in psychotropic medication prescriptions for children and adolescents.
Steinhausen HC
Eur Child Adolesc Psychiatry; 2015 Jun; 24(6):635-40. PubMed ID: 25378107
[TBL] [Abstract][Full Text] [Related]
77. Adherence in liver transplant recipients.
Burra P; Germani G; Gnoato F; Lazzaro S; Russo FP; Cillo U; Senzolo M
Liver Transpl; 2011 Jul; 17(7):760-70. PubMed ID: 21384527
[TBL] [Abstract][Full Text] [Related]
78. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
[TBL] [Abstract][Full Text] [Related]
79. Enhancing medication adherence: clinician outcomes from the Medication Alliance training program.
Byrne MK; Deane FP; Lambert G; Coombs T
Aust N Z J Psychiatry; 2004 Apr; 38(4):246-53. PubMed ID: 15038804
[TBL] [Abstract][Full Text] [Related]
80. Psychotropic medication use in French children and adolescents.
Kovess V; Choppin S; Gao F; Pivette M; Husky M; Leray E
J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):168-75. PubMed ID: 25584837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
